Literature DB >> 1082795

Lymphocyte abnormalities in untreated patients with Hodgkin's disease.

G Holm, H Mellstedt, M Björkholm, B Johansson, D Killander, R Sundblad, G Söderberg.   

Abstract

The study comprises 38 unselected and untreated patients with Hodgkin's disease (HD) and 23 healthy persons. Highly purified blood lymphocytes were analyzed for cells forming rosettes with sheep red blood cells (T lymphocytes), and lymphocytes bearing surface immunoglobulin (B lymphocytes) and/or carrying receptors for complement. Their DNA synthesis, spontaneously, or after activation with mitogens (phytohemagglutinin, concanavallin A, poke weed mitogen) and purified protein derivative (PPD) was measured. Delayed skin hypersensitivity to PPD and mumps antigen was studied. Most HD patients had low numbers of T lymphocytes (50% of the cases below normal range) while the mean B-lymphocyte level was normal but with a greater variation than in the control group. Lymphocytes from most patients were poorly stimulated by T-cell mitogens. Two-thirds of the patients and one healthy control had negative skin reaction to 2 TU PPD and the DNA synthesis of their lymphocytes after activation with PPD was low. Large lymphoid cells (greater than 9-mm diameter) were commonly present in HD blood and the spontaneous DNA synthesis was high, particularly in lymphocytes from stage B patients. The percentage of T lymphocytes and the stimulation of lymphocytes by T-cell mitogens or by PPD, a T-lymphocyte function, did not correlate and each test only detected defects in about half the cases. Simultaneous application of all tests revealed abnormalities of blood T lymphocytes in 33 out of 38 patients. Although the defects were usually more pronounced in patients with advanced disease, the impairment of T lymphocytes and their functions is present in all stages of Hodgkin's disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1082795     DOI: 10.1002/1097-0142(197602)37:2<751::aid-cncr2820370223>3.0.co;2-2

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

1.  Acute energy deprivation in man: effect on cell-mediated immunological reactions.

Authors:  G Holm
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

Review 2.  [Hodgkin's disease. Results in diagnosis and treatment (author's transl)].

Authors:  D Huhn; W Wilmanns
Journal:  Klin Wochenschr       Date:  1979-04-17

3.  Intrinsic B lymphocyte defect in untreated patients with Hodgkin's disease.

Authors:  F Griesinger; L Bergmann; R Barot-Ciorbaru; P S Mitrou
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

4.  Hemangiopericytoma of the heart following treatment of Hodgkin's disease. A case report.

Authors:  K W Schmid; J Thurner; K Gruenewald
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1987

5.  Persisting lymphocyte deficiences during remission in Hodgkin's disease.

Authors:  M Björkholm; G Holm; H Mellstedt
Journal:  Clin Exp Immunol       Date:  1977-06       Impact factor: 4.330

6.  A simple method for electronic counting of rosette forming human blood lymphocytes.

Authors:  G Sandberg; M Björkholm
Journal:  Clin Exp Immunol       Date:  1985-02       Impact factor: 4.330

7.  Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.

Authors:  M Björkholm; G Holm; J Askergren; H Mellstedt
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

8.  Spontaneous and antibody-dependent cellular cytotoxicity by lymphocyte subpopulations in peripheral blood and spleen from adult untreated patients with Hodgkin's disease.

Authors:  S Gupta; G Fernandes
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

9.  Monocyte function in Hodgkin's disease.

Authors:  G Holm; M Björkholm; B Johansson; H Mellstedt; C Lindemalm
Journal:  Clin Exp Immunol       Date:  1982-01       Impact factor: 4.330

10.  [The influence on PHA-stimulation by inhibition of prostaglandin synthesis in vitro in patients with Hodgkin's disease (author's transl)].

Authors:  H W Pees; G Girmann; J Schwamborn
Journal:  Blut       Date:  1980-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.